Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

111 results
Display

Serious Necrotizing Enterocolitis in a Neonate Treated with Octreotide for Congenital Chylothorax

Jo MJ, Kim DH, Kim HS

The somatostatin analog octreotide has recently been introduced in the treatment of infants with chylothorax. The safety profile of octreotide has not been fully evaluated. Octreotide reduces the splanchnic blood...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Comparison of the Efficacy of Octreotide Long-acting Repeatable and Lanreotide Autogel in Acromegalic Patients

Park JK, Lee EJ

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Letter: Comparison of the Efficacy of Octreotide Long-acting Repeatable and Lanreotide Autogel in Acromegalic Patients (J Korean Endocr Soc 25:37-45, 2010)

Ahn YB

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Hepatic Carcinoid Tumor Regression with Octreotide

Choi HJ, Woo SK, Suh KH, Baek SM, Baek HJ, Lee SM, Kim WH, Kim SH, Kim IS, Shon KR

  • KMID: 2241270
  • Korean J Hepatol.
  • 2001 Mar;7(1):100-103.
Somatostatin analogue octreotide is commonly used for the treatment of carcinoid syndrome. Octreotide also has an antiproliferative effect in neuroendocrine tumors and has demonstrated tumor reduction in patients having advanced...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Efficacy of the Prophylactic Use of Octreotide after a Pancreaticoduodenectomy

Moon HJ, Heo JS, Choi SH, Joh JW, Choi DW, Kim YI

  • KMID: 2428294
  • Yonsei Med J.
  • 2005 Dec;46(6):788-793.
This study was performed to analyze the efficacy of the prophylactic use of octreotide (Novartis, Stein, Switzerland) for pancreatic fistula following a pancreaticoduodenectomy. The medical records of 190 patients who...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Trial of Ocrteotide in the Theatment of Severe Acute Pancreatitis

Kim NS, Lim CS, Lee SO, Kim JK, Lee ST, Kim DG, Ahn DS

  • KMID: 1556961
  • Korean J Gastroenterol.
  • 1998 Nov;32(5):664-668.
BACKGROUND/AIMS: Somatostatin and its long acting analogue octreotide have been proposed for the treatment of patients with acute pancreatitis. But neither agents has been adequately assessed in patient with severe...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Two cases of postoperative chylothorax treated with parenteral octreotide and conservative therapy

Choi EJ, Lee S

Chylothorax is a rare complication following cardiac surgery for congenital heart diseases. Although conservative management is successful in the majority of cases, surgical intervention is required in a refractory one....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Treatment of Congenital Chylothorax in a Premature Infant using Octreotide

Ahn YJ, Jeon YH, Kim SS, Park JO, Kim CH

  • KMID: 2099112
  • J Korean Soc Neonatol.
  • 2006 Nov;13(2):261-266.
Chylothorax, defined as escape of chyle from the thoracic duct into the thoracic cavity, is the most common cause of pleural effusion during the neonatal period. The use of octreotide,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
An Acromegalci Patient with Marked Tumor Shrinkoge after Continuous Infusion of Octreotide

Han JH, Son HS, Yoon KH, Cha BY, Lee KW, Son HY, Kang SK, Ahn YB, Jang SA, Song KH, Yoo SJ, Lee JM

  • KMID: 2461557
  • J Korean Soc Endocrinol.
  • 1994 Jun;10(2):161-164.
No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Response: Comparison of the Efficacy of Octreotide Long-acting Repeatable and Lanreotide Autogel in Acromegalic Patients (J Korean Endocr Soc 25:37-45, 2010)

Kim SY, Kim D

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Preoperative treatment of acromegaly with long-acting somatostatin analog octreotide

Lee SI, Kim HK, Ko KS, Park KS, Kim SY, Cho BY, Lee HK, Koh CS, Min HK, Kim HJ, Jeong HW, Han DH

  • KMID: 1686840
  • J Korean Soc Endocrinol.
  • 1993 Mar;8(1):35-41.
No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effects of octreotide on the contractility of isolated rat vas deferens

Jang SA, Kwon OC, Ha JH, Lee KY, Kim WJ

This study was performed to investigate the effect of octreotide on the contractility of rat vas deferens. The -smooth muscle strips isolated from the prostatic portion were myographied in isolated...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effect of Octreotide on Patients with Malignant Bowel Obstruction

Park JC, Jang YS, Jeon EK, Kim DK, Lee WH, Lee GJ, You SY, Choi HH, Park SY

  • KMID: 2305370
  • Korean J Hosp Palliat Care.
  • 2009 Dec;12(4):194-198.
PURPOSE: Malignant bowel obstruction causes gastrointestinal symptoms and leads to diminished quality of life in patients with advanced cancer. Several studies have shown the efficacy of octreotide for the relief...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Experience of Somatostatin Analogue in Various Pancreatic Diseases

Kim HY, Lee SS, Shin YR, Jun BM, Pyo SI, Park HJ, You KS, Seo DW, Lee SK, Kim MH, Min YI

  • KMID: 1857612
  • Korean J Gastroenterol.
  • 2000 Jun;35(6):784-789.
BACKGROUND/AIMS: Octreotide, long-acting analogue of somatostatin, has been used for symptomatic carcinoid syndrome and vasoactive intestinal peptide-producing tumors. In pancreatic diseases, however, the effect of octreotide has not been settled...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Conservative Treatment with Octreotide as an Adjunct for Chylothorax after Lung Cancer Surgery: Two Cases

Song SW, Lee HS, Kim MS, Lee JM, Kim JH, Zo JI

  • KMID: 1916245
  • Korean J Thorac Cardiovasc Surg.
  • 2006 Jul;39(7):561-564.
Postoperative chylothorax is a rare but serious complication of thoracic surgical procedures. We report two cases of chylothorax after lobectomy and mediastinal lymph node dissection for lung cancer. The patients...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Is there a relationship between beginning time and efficiency of octreotide in the treatment of experimental acute pancreatitis?

Kafali ME, Gul M, Alptekin H, Sahin M, Toy H, Akoz M

  • KMID: 2324824
  • J Korean Surg Soc.
  • 2012 May;82(5):296-301.
PURPOSE: The efficacy of octreotide in the treatment of acute pancreatitis is controversial. Octreotide treatment for acute pancreatitis often shows poor correlation between results obtained in experimental studies and results...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Intestinal Lymphangiectasia Improved with Antiplasmin and Octreotide Treatment

Yu SK, Choi JM, Yoo JH, Kim DK, Shin SJ, Lee KM, Yoo BM, Hahm KB, Kim JH, Han JH

  • KMID: 2143664
  • Korean J Gastrointest Endosc.
  • 2006 Oct;33(4):248-252.
Intestinal lymphangiectasia is characterized by protein- losing enteropathy, and is diagnosed by a small bowel biopsy demonstrating dilated lymphatics in the mucosa, submucosa and serosa in the absence of coexistent...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Mediastinal Pacreatic Pseudocyst Treated with Octreotide

Park SH, Kim SJ, Kim EJ, Lee MH, Kim HS, Chung IK, Kim C, Lee CW

  • KMID: 2084965
  • Korean J Gastroenterol.
  • 1999 Sep;34(3):417-421.
Pancreatic pseudocyst is a common complication of acute pancreatitis, which may occur at any site of pancreas and extrapancreatic tissue. In mediastinal pseudocyst, the most common route of dissemination into...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Malignant Insulinoma Resistant to Octreotide and Combination Chemotherapy

Kim DK, Kwon HC, Lee JI, Kang DY, Kim JS, Kim HJ, Kim JS

  • KMID: 2461577
  • J Korean Soc Endocrinol.
  • 1994 Sep;10(3):300-305.
Insulinoma is insulin-secreting tumor that almost all originate in the pancreas and cause symptoms related to hypoglycemia. The documentation of metastatic lesions by imaging studies, is only accurate mean of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Sustained Maintenance of Normal Insulin-like Growth Factor-I during Pregnancy and Successful Delivery in an Acromegalic Patient with Octreotide-LAR(R) Treatment

Kim SK, Jung JH, Kim JH, Hur KY, Tan AH, Kim HK, Lee JI, Chung HS, Kim KW

We report here on a 34-year-old Korean woman with active acromegaly and who received Octreotide-LAR(R) for 12 months following transsphenoidal pituitary surgery. During Octreotide-LAR(R) treatment, the clinical improvement was paralleled...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr